Status:
COMPLETED
Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Aspergillosis
Candidiasis
Eligibility:
All Genders
3-17 years
Phase:
PHASE2
Brief Summary
This study is an open label, noncomparative study using an investigational agent for the treatment of documented Candida or Aspergillus infections in pediatric patients (ages 3 months-17 years).
Eligibility Criteria
Inclusion
- Children, 3 months through 17 years of age,
- with esophageal candidiasis or
- invasive candidiasis or
- children requiring salvage treatment of invasive aspergillosis.
Exclusion
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00082524
Start Date
April 1 2004
End Date
July 1 2007
Last Update
February 23 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.